News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Maynard Ryan D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Maynard Ryan D (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 51,955 options to buy
@ $0 |
|
| 09/14/2022 |
4
| Maynard Ryan D (CFO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 225,000 options to buy
@ $10.75, valued at
$2.4M
|
|
| 09/14/2022 |
3
| Maynard Ryan D (CFO) has filed a Form 3 on Cara Therapeutics, Inc. |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2020 |
4
| Maynard Ryan D (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 35,000 options to buy
@ $32.17, valued at
$1.1M
|
|
| 06/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2018 |
4
| Maynard Ryan D (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 35,000 options to buy
@ $14.45, valued at
$505.8k
|
|
| 11/07/2017 |
4
| Maynard Ryan D (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Sold 100,000 shares
@ $3.9, valued at
$390k
Exercised 100,000 options to buy
@ $2.14, valued at
$214k
|
|
| 06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/14/2012 |
4/A
| Maynard Ryan D (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Sold 23,302 shares
@ $10.6669, valued at
$248.6k
Exercised 23,302 options to buy
@ $6.49, valued at
$151.2k
|
|
| 09/14/2012 |
4
| Maynard Ryan D (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Exercised 23,302 shares
@ $6.49, valued at
$151.2k
Sold 23,302 shares
@ $10.6669, valued at
$248.6k
Exercised 23,302 options to buy
@ $6.49, valued at
$151.2k
|
|
| 09/11/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/09/2012 |
4
| Maynard Ryan D (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Sold 700 shares
@ $10.6, valued at
$7.4k
Sold 100 shares
@ $10.61, valued at
$1.1k
Sold 600 shares
@ $10.62, valued at
$6.4k
Sold 300 shares
@ $10.625, valued at
$3.2k
Exercised 1,700 options to buy
@ $6.49, valued at
$11k
|
|
| 01/27/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2011 |
4
| Maynard Ryan D (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 65,000 options to buy
@ $6.73, valued at
$437.5k
|
|
| 06/01/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/25/2010 |
4
| Maynard Ryan D (VP, CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 85,000 options to buy
@ $9.62, valued at
$817.7k
|
|
| 03/31/2009 |
4
| Maynard Ryan D (VP, CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC |
|
|